NL-OMON22921已完成不适用
Second IVIg Dose in Guillain-Barre syndrome patients with poor prognosis.
Erasmus MC Rotterdam0 个研究点目标入组 176 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 176
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •To enter this GBS study:
- •1. Patients are diagnosed with GBS[30];
排除标准
- •1. Age less than 6 years;
- •2. Patient known to have a severe allergic reaction to properly matched blood products or plasma products;
研究者
相似试验
已完成
不适用
Second IVIg Dose in GBS patients with poor prognosis (SID-GBS trial)acute inflammatory demyelinating polyneuropathy (AIDP)Guillain-Barre syndrome1000381610034606NL-OMON47229Erasmus MC, Universitair Medisch Centrum Rotterdam339
进行中（未招募）
不适用
Second IVIg Dose in GBS patients with poor prognosis (SID-GBS trial)EUCTR2008-005659-83-NLErasmus MC
招募中
不适用
Efficacy of Intravenous Gamma Globulin on Guillain-Barre SyndromeGuillain-barre SyndromeNCT04303962Ning Wang, MD., PhD.200
已完成
2 期
JET-GBS - Japanese Eculizumab Trial for GBSGullain Barre SyndromeNCT02493725Chiba University34
已完成
2 期
A Study of Imlifidase in Patients With Guillain-Barré SyndromeGuillain-Barré Syndrome (GBS)NCT03943589Hansa Biopharma AB30